Michael Schneider1, Mitchell Haas, Ronald Glick, Joel Stevans, Doug Landsittel. 1. *School of Health and Rehabilitation Sciences, Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA †Center for Outcomes Studies, University of Western States, Portland, OR ‡Department of Psychiatry and Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Center for Integrative Medicine at UPMC Shadyside, Pittsburgh, PA §School of Health and Rehabilitation Sciences University of Pittsburgh, Pittsburgh, PA; and ¶Department of Medicine and Department of Biostatistics, Clinical & Translational Science Institute, Center for Research on Health Care Data Center, University of Pittsburgh, Pittsburgh, PA.
Abstract
STUDY DESIGN: Randomized controlled trial with follow-up to 6 months. OBJECTIVE: This was a comparative effectiveness trial of manual-thrust manipulation (MTM) versus mechanical-assisted manipulation (MAM); and manipulation versus usual medical care (UMC). SUMMARY OF BACKGROUND DATA: Low back pain (LBP) is one of the most common conditions seen in primary care and physical medicine practice. MTM is a common treatment for LBP. Claims that MAM is an effective alternative to MTM have yet to be substantiated. There is also question about the effectiveness of manipulation in acute and subacute LBP compared with UMC. METHODS: A total of 107 adults with onset of LBP within the past 12 weeks were randomized to 1 of 3 treatment groups: MTM, MAM, or UMC. Outcome measures included the Oswestry LBP Disability Index (0-100 scale) and numeric pain rating (0-10 scale). Participants in the manipulation groups were treated twice weekly during 4 weeks; subjects in UMC were seen for 3 visits during this time. Outcome measures were captured at baseline, 4 weeks, 3 months, and 6 months. RESULTS: Linear regression showed a statistically significant advantage of MTM at 4 weeks compared with MAM (disability = -8.1, P = 0.009; pain = -1.4, P = 0.002) and UMC (disability = -6.5, P = 0.032; pain = -1.7, P < 0.001). Responder analysis, defined as 30% and 50% reductions in Oswestry LBP Disability Index scores revealed a significantly greater proportion of responders at 4 weeks in MTM (76%; 50%) compared with MAM (50%; 16%) and UMC (48%; 39%). Similar between-group results were found for pain: MTM (94%; 76%); MAM (69%; 47%); and UMC (56%; 41%). No statistically significant group differences were found between MAM and UMC, and for any comparison at 3 or 6 months. CONCLUSION:MTM provides greater short-term reductions in self-reported disability and pain scores compared with UMC or MAM. LEVEL OF EVIDENCE: 2.
RCT Entities:
STUDY DESIGN: Randomized controlled trial with follow-up to 6 months. OBJECTIVE: This was a comparative effectiveness trial of manual-thrust manipulation (MTM) versus mechanical-assisted manipulation (MAM); and manipulation versus usual medical care (UMC). SUMMARY OF BACKGROUND DATA: Low back pain (LBP) is one of the most common conditions seen in primary care and physical medicine practice. MTM is a common treatment for LBP. Claims that MAM is an effective alternative to MTM have yet to be substantiated. There is also question about the effectiveness of manipulation in acute and subacute LBP compared with UMC. METHODS: A total of 107 adults with onset of LBP within the past 12 weeks were randomized to 1 of 3 treatment groups: MTM, MAM, or UMC. Outcome measures included the Oswestry LBP Disability Index (0-100 scale) and numeric pain rating (0-10 scale). Participants in the manipulation groups were treated twice weekly during 4 weeks; subjects in UMC were seen for 3 visits during this time. Outcome measures were captured at baseline, 4 weeks, 3 months, and 6 months. RESULTS: Linear regression showed a statistically significant advantage of MTM at 4 weeks compared with MAM (disability = -8.1, P = 0.009; pain = -1.4, P = 0.002) and UMC (disability = -6.5, P = 0.032; pain = -1.7, P < 0.001). Responder analysis, defined as 30% and 50% reductions in Oswestry LBP Disability Index scores revealed a significantly greater proportion of responders at 4 weeks in MTM (76%; 50%) compared with MAM (50%; 16%) and UMC (48%; 39%). Similar between-group results were found for pain: MTM (94%; 76%); MAM (69%; 47%); and UMC (56%; 41%). No statistically significant group differences were found between MAM and UMC, and for any comparison at 3 or 6 months. CONCLUSION: MTM provides greater short-term reductions in self-reported disability and pain scores compared with UMC or MAM. LEVEL OF EVIDENCE: 2.
Authors: Dana J Lawrence; William Meeker; Richard Branson; Gert Bronfort; Jeff R Cates; Mitch Haas; Michael Haneline; Marc Micozzi; William Updyke; Robert Mootz; John J Triano; Cheryl Hawk Journal: J Manipulative Physiol Ther Date: 2008 Nov-Dec Impact factor: 1.437
Authors: Michael J Schneider; Jennifer Brach; James J Irrgang; Katherine Verdolini Abbott; Stephen R Wisniewski; Anthony Delitto Journal: J Manipulative Physiol Ther Date: 2010 Mar-Apr Impact factor: 1.437
Authors: Sidney M Rubinstein; Caroline B Terwee; Willem J J Assendelft; Michiel R de Boer; Maurits W van Tulder Journal: Spine (Phila Pa 1976) Date: 2013-02-01 Impact factor: 3.468
Authors: Robert H Dworkin; Dennis C Turk; Michael P McDermott; Sarah Peirce-Sandner; Laurie B Burke; Penney Cowan; John T Farrar; Sharon Hertz; Srinivasa N Raja; Bob A Rappaport; Christine Rauschkolb; Cristina Sampaio Journal: Pain Date: 2009-12 Impact factor: 6.961
Authors: Joshua A Cleland; Julie M Fritz; Kornelia Kulig; Todd E Davenport; Sarah Eberhart; Jake Magel; John D Childs Journal: Spine (Phila Pa 1976) Date: 2009-12-01 Impact factor: 3.468
Authors: William R Reed; Joel G Pickar; Randall S Sozio; Michael A K Liebschner; Joshua W Little; Maruti R Gudavalli Journal: J Manipulative Physiol Ther Date: 2017-06-17 Impact factor: 1.437
Authors: Brian C Clark; David W Russ; Masato Nakazawa; Christopher R France; Stevan Walkowski; Timothy D Law; Megan Applegate; Niladri Mahato; Samuel Lietkam; James Odenthal; Daniel Corcos; Simeon Hain; Betty Sindelar; Robert J Ploutz-Snyder; James S Thomas Journal: Contemp Clin Trials Date: 2018-05-21 Impact factor: 2.226